0001586571-15-000001.txt : 20150325 0001586571-15-000001.hdr.sgml : 20150325 20150324180126 ACCESSION NUMBER: 0001586571-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150325 DATE AS OF CHANGE: 20150324 EFFECTIVENESS DATE: 20150325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curoverse, Inc. CENTRAL INDEX KEY: 0001586571 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-236561 FILM NUMBER: 15722791 BUSINESS ADDRESS: STREET 1: 332 CONGRESS STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-937-2300 MAIL ADDRESS: STREET 1: 332 CONGRESS STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Clinical Future, Inc. DATE OF NAME CHANGE: 20130911 D 1 primary_doc.xml X0707 D LIVE 0001586571 Curoverse, Inc. 332 CONGRESS STREET 4TH FLOOR BOSTON MA MASSACHUSETTS 02210 617-937-2300 DELAWARE Clinical Future, Inc. Corporation true 2010 Adam Berrey 332 Congress Street 4th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Director Alexander Wait Zaranek 332 Congress Street 4th Floor Boston MA MASSACHUSETTS 02210 Director David Martirano 332 Congress Street 4th Floor Boston MA MASSACHUSETTS 02210 Director Jeremy Allaire 332 Congress Street 4th Floor Boston MA MASSACHUSETTS 02210 Director Ward Vandewege 332 Congress Street 4th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Clay Throp 332 Congress Street 4th Floor Boston MA MASSACHUSETTS 02210 Director Other Decline to Disclose 06b false 2015-03-09 false true false 0 2000000 500000 1500000 false 3 0 0 0 false Curoverse, Inc. /s/ Adam Berrey Adam Berrey President 2015-03-24